Company Filing History:
Years Active: 2003
Title: Kim L Berg: Innovator in Nucleic Acid Research
Introduction
Kim L Berg is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acids. His work has implications for diagnostics and therapeutic compositions, showcasing the potential of his inventions in medical applications.
Latest Patents
Kim L Berg holds a patent for "Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis." This invention provides genomic sequences of a library of purified nucleic acid molecules, or their complements, comprising the genome of Moraxella catarrahalis. The patent also identifies open reading frames contained within these nucleic acid molecules. Furthermore, it outlines the use of these nucleic acid molecules, their complements, or fragments, along with proteins or portions thereof, for identifying ligands and developing useful diagnostic and therapeutic compositions. The invention also includes vectors, host cells, and methods for producing proteins or portions thereof.
Career Highlights
Kim L Berg is associated with Elitra Pharmaceuticals Inc., where he continues to advance his research and innovations. His work at the company reflects his commitment to developing groundbreaking solutions in the field of biotechnology.
Collaborations
Throughout his career, Kim has collaborated with notable colleagues, including Robert E Lagace and Chandra Patterson. These collaborations have likely contributed to the success and impact of his research.
Conclusion
Kim L Berg's contributions to nucleic acid research exemplify the innovative spirit of modern science. His patent and ongoing work at Elitra Pharmaceuticals Inc. highlight the importance of his inventions in the medical field.